Vaccination in preterm and low birth weight infants in India.

Santosh Soans, Attila Mihalyi, Valerie Berlaimont, Shafi Kolhapure, Resham Dash, Ashish Agrawal

Journal: Human vaccines & immunotherapeutics 2022;18(1):1-12

PMID: 33599562

Abstract

In India, the high neonatal and infant mortality rate is due in part to an increasing number of preterm and low birth weight (LBW) infants. Given the immaturity of immune system, these infants are at an increased risk of hospitalization and mortality from vaccine-preventable diseases (VPDs). In this narrative review, we screened the scientific literature for data on the risk of VPDs, vaccination delay and factors related to it in Indian preterm and LBW infants. Although routine childhood vaccinations are recommended regardless of gestational age or birth weight, vaccination is often delayed. It exposes these infants to a higher risk of infections, their associated complications, and death. After-birth complications, lack of awareness of recommendations, vaccine efficacy and effectiveness and concerns related to safety are some of the common barriers to vaccination. Awareness campaigns might help substantiate the need for (and value of) vaccination in preterm and LBW infants.

Address: Paediatrics, AJ Institute of Medical Sciences, Mangalore, India.; Medical Affairs and Clinical R&D, GSK Vaccines Europe, Wavre, Belgium.; Global Medical Affairs, GSK, Wavre, Belgium.; Medical Affairs Department, GSK, Mumbai, India.; Medical Affairs Department, GSK, Bengaluru, India.; Medical Affairs Department, GSK, Hyderabad, India.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.